Repaglinide and Xeloda drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Repaglinide (repaglinide) and Xeloda (capecitabine). Common drug interactions include asthenia among females and adenocarcinoma pancreas among males.

The phase IV clinical study analyzes what interactions people have when they take Repaglinide and Xeloda. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Repaglinide?

Repaglinide has active ingredients of repaglinide. It is often used in diabetes. eHealthMe is studying from 8,226 Repaglinide users. Check the latest studies of Repaglinide.

What is Xeloda?

Xeloda has active ingredients of capecitabine. It is often used in colon cancer. eHealthMe is studying from 46,649 Xeloda users. Check the latest studies of Xeloda.

On Jul, 10, 2026

14 people who take Repaglinide and Xeloda together, and have interactions are studied.

Repaglinide and Xeloda drug interactions.

What are the common drug interactions of Repaglinide and Xeloda, by gender? *:

female:

Asthenia (weakness)
Dyspnoea (difficult or laboured respiration)
Escherichia urinary tract infection (urinary tract infection by escherichia coli)
Osteonecrosis of jaw (death of bone of jaw)
Sepsis (a severe blood infection that can lead to organ failure and death)
Bone loss
Cardiomegaly (increased size of heart than normal)
Diverticulum intestinal (a pouch that is attached to the first part of the small intestine)
Emotional distress
Fall

male:

Adenocarcinoma pancreas (cancer of pancreas)
Bacterial sepsis
Pulmonary fibrosis (formation or development of excess fibrous connective tissue (fibrosis) in the lungs)
Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart)
Bone marrow failure
Cardiomyopathy (weakening of the heart muscle)
Encephalopathy (functioning of the brain is affected by some agent or condition)
Interstitial lung disease
Mucosal inflammation (infection of mucous membrane)

What are the common drug interactions of Repaglinide and Xeloda, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Asthenia (weakness)
Dyspnoea (difficult or laboured respiration)
Escherichia urinary tract infection (urinary tract infection by escherichia coli)
Sepsis (a severe blood infection that can lead to organ failure and death)

50-59:

n/a

60+:

Osteonecrosis of jaw (death of bone of jaw)
Bone loss
Loose tooth
Metastases to neck (cancer spreads to neck)
Nephrolithiasis (calculi in the kidneys)
Non-hodgkin's lymphoma (malignant (cancer) cells form in the lymph system)
Ovarian cyst (fluid filled sac of the ovary)
Periarthritis (inflammation of the external coats of an artery and of the tissues around the artery)
Pulmonary arterial hypertension (high blood pressure in the arteries of lungs)
Quality of life decreased

What are the existing conditions these people have? *

Pancreatic Neuroendocrine Tumor Metastatic: 3 people, 21.43%
Pain: 2 people, 14.29%
Metastases To Bone (cancer spreads to bone): 2 people, 14.29%
Rectal Neoplasm (tumour of rectum): 1 person, 7.14%
Rectal Cancer Metastatic (cancer of rectum spreads to other): 1 person, 7.14%
Gastrointestinal Neoplasm (cancer tumour of digestive tract): 1 person, 7.14%
Breast Cancer Metastatic: 1 person, 7.14%
Adenocarcinoma Pancreas (cancer of pancreas): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Repaglinide and Xeloda?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously